RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
RT @mohamed_abazeed: Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX d…
Margarite Mattosian, MD/PhD @TulaneMedicine, on drug-target combinations in translational models. Developed TNBC PDX despite limited resources and a hurricane! Important to incorporate models from distinct ethnicity. Look forward to more collaborations! ht